Price T Rowe Associates Inc Pulmonx Corp Transaction History

Price T Rowe Associates Inc

  • $812 Billion
  • Q1 2025

A detailed history of Price T Rowe Associates Inc transactions in Pulmonx Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 36,142 shares of LUNG stock, worth $106,980. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,142
Previous 33,585 7.61%
Holding current value
$106,980
Previous $229,000 6.55%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
BUY
$5.68 - $9.22 $14,523 - $23,575
2,557 Added 7.61%
36,142 $244,000
Q4 2024

Feb 14, 2025
SELL
$5.93 - $7.71 $55,878 - $72,651
-9,423 Reduced 21.91%
33,585 $229,000
Q3 2024

Nov 14, 2024
BUY
$5.59 - $8.58 $1,671 - $2,565
299 Added 0.7%
43,008 $357,000
Q2 2024

Aug 14, 2024
BUY
$5.77 - $9.82 $40,326 - $68,631
6,989 Added 19.57%
42,709 $271,000
Q1 2024

May 15, 2024
BUY
$8.71 - $14.65 $14,223 - $23,923
1,633 Added 4.79%
35,720 $332,000
Q4 2023

Feb 14, 2024
BUY
$7.89 - $13.14 $4,576 - $7,621
580 Added 1.73%
34,087 $435,000
Q3 2023

Nov 14, 2023
BUY
$9.88 - $14.0 $37,040 - $52,486
3,749 Added 12.6%
33,507 $347,000
Q2 2023

Aug 14, 2023
BUY
$10.78 - $13.65 $31,941 - $40,444
2,963 Added 11.06%
29,758 $391,000
Q1 2023

May 15, 2023
BUY
$7.49 - $12.54 $5,175 - $8,665
691 Added 2.65%
26,795 $300,000
Q4 2022

Feb 14, 2023
BUY
$4.92 - $17.35 $3,483 - $12,283
708 Added 2.79%
26,104 $220,000
Q3 2022

Nov 14, 2022
BUY
$15.35 - $23.99 $31,206 - $48,771
2,033 Added 8.7%
25,396 $424,000
Q2 2022

Aug 15, 2022
BUY
$14.0 - $27.95 $33,278 - $66,437
2,377 Added 11.33%
23,363 $344,000
Q1 2022

May 16, 2022
SELL
$21.13 - $35.65 $4,162 - $7,023
-197 Reduced 0.93%
20,986 $521,000
Q4 2021

Feb 14, 2022
SELL
$29.72 - $45.1 $11.6 Million - $17.6 Million
-390,204 Reduced 94.85%
21,183 $679,000
Q3 2021

Nov 15, 2021
BUY
$35.98 - $44.48 $786,522 - $972,332
21,860 Added 5.61%
411,387 $14.8 Million
Q2 2021

Aug 16, 2021
SELL
$37.61 - $48.0 $12.4 Million - $15.8 Million
-328,396 Reduced 45.74%
389,527 $17.2 Million
Q1 2021

May 17, 2021
BUY
$44.0 - $67.54 $15.3 Million - $23.5 Million
348,008 Added 94.08%
717,923 $32.8 Million
Q4 2020

Feb 16, 2021
BUY
$39.31 - $69.02 $14.5 Million - $25.5 Million
369,915 New
369,915 $25.5 Million

Others Institutions Holding LUNG

# of Institutions
127
Shares Held
32.5M
Call Options Held
2.6K
Put Options Held
216K
View Full List

About Pulmonx Corp

LUNG Quotes by TradingView
  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $110M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email